Abstract
Aminoglutethimide, a drug known to block adrenal steroidogensis and peripheral aromatization of androgens to estrogens, has been found effective in the treatment of breast cancer. The drug has been used in our Institute to treat 71 consecutive metastatic breast cancer patients. Of 67 patients evaluable for response, 9 (13.4%) have achieved a partial response, 30 (44.7%) stable disease, and 28 (41.7%) progression of disease. Four patients were taken off the therapy because of drug-related toxicity.
| Original language | English |
|---|---|
| Pages (from-to) | 297-300 |
| Number of pages | 4 |
| Journal | Tumori |
| Volume | 71 |
| Issue number | 3 |
| Publication status | Published - 1985 |
ASJC Scopus subject areas
- Cancer Research
Fingerprint Dive into the research topics of 'Aminoglutethimide as second-line endocrine treatment in metastatic breast cancer'. Together they form a unique fingerprint.
Cite this
Pronzato, P., Ardizzoni, A., Lionetto, R., Conte, P., & Rosso, R. (1985). Aminoglutethimide as second-line endocrine treatment in metastatic breast cancer. Tumori, 71(3), 297-300.